Advice for managing Covid-19 pain and fever safely at home
Drickus Maartens • July 29, 2020
Even the safest painkiller must be used with care, pharmacist warns
Fever, body aches and pain are among the commonly reported symptoms of Covid-19 and are also associated with other viral infections, including influenza. While these symptoms can be most unpleasant, frequently they can be managed at home on the advice of a healthcare professional. It is crucial, however, that medications for relieving symptoms are always used appropriately and safely, a pharmacist warns.
“Many Covid-19 patients describe experiencing severe headaches, body aches, sore throat and chest pain, and the most common symptoms reported are fever, chills, and shivers. Paracetamol has been proposed as the safest drug for relief of these symptoms, particularly pain and fever, for most of the population,” says pharmacist Ria Westerman of Medipost Pharmacy, South Africa’s largest national courier pharmacy.
“Even though paracetamol is effective and very safe even for pregnant women and babies, as with all medicines, it is extremely important not to exceed the dosage that is specified on the packaging or recommended by your treating doctor. When taken in excessive doses, an overdose of this safe medicine can lead to toxic effects on the body,” she explains.
How paracetamol can be helpful for Covid-19 home care
Fever – a heightened body temperature of 37.5 degrees Celsius or more – is common in our bodies’ response to an infection such as Covid-19.
“It has been noted that in certain cases, the pain and fever and other symptoms of the illness can feel so bad that the person becomes anxious and may even experience panic attacks, which could potentially worsen their situation. Fortunately fever, aches and pains can be effectively managed with paracetamol, which is inexpensive and readily available without the need for a doctor’s prescription.”
Paracetamol still regarded as safest, 65 years later
“Before the introduction of Paracetamol in 1955, all the other painkillers that were available either had unpleasant side-effects or a significant risk of the patient experiencing a bad reaction to the medicine. The development of paracetamol was an enormous breakthrough, and even up to this day it is still considered the safest analgesic [meaning ‘pain alleviating’] and anti-pyretic [meaning ‘fever reducing’] medicine available,” she explains.
Although paracetamol is safe for all ages, from babies to adults, with very few side-effects and little interaction with other types of medicine, Westerman emphasises that all medicines should be used with care and only as advised.
Avoiding overdose
“There are many products containing paracetamol, which is the generic name for the compound, and it is available under many different brand names either as a single ingredient or in combination with other ingredients. Accidental overdose is unfortunately common, but can be avoided. If you are taking more than one type of medicine, it is important to check all the ingredients to ensure you do not exceed the safe dosage for paracetamol.”
The standard dose for adults is 500mg (one tablet) to 1000mg (two tablets) four times per day. This means that 1000mg, or one gram, is the maximum dose for an adult in a six-hour period, which should never be exceeded, with a maximum of 4000mg (i.e. four grams equivalent to eight tablets) in 24 hours.
“Unlike most other types of painkillers, paracetamol can be taken on an empty stomach without causing irritation. In terms of pain relief properties, this is significant as paracetamol can be more rapidly absorbed, bringing more intense relief sooner than most other common oral analgesics. It is a gentle yet powerful painkiller,” she says.
Caution for some
Westerman points out that paracetamol is unfortunately not suitable for people with liver or hepatic impairment, as it is metabolised or processed through the liver. “As alcohol dependence can affect liver function, these patients should seek their doctor’s advice and only take paracetamol on their recommendation,” Westerman advises.
“There are very few interactions with other medications, of which the most significant is the interaction with anticoagulants (blood thinning), such as Warfarin, and people on such treatments should only take paracetamol under supervision or on the recommendation of a physician.”
People who make use of Medipost Pharmacy’s chronic medication delivery service or self-medication online shop https://shop.medipost.co.za have access to telephonic clinical advice from pharmacists and pharmacist’s assistants in their preferred official South African language to discuss dosage, possible side-effects or interactions and any other concerns relating to their medication. This service is available from Monday to Friday, 08h00 to 22h00, and Saturdays between 08h00 and 12h00.
“Although most people who fall ill with Covid-19 are able to recover at home with symptomatic relief, it is important to keep in regular contact with one’s treating doctor and seek medical attention immediately if symptoms worsen. It may also be reassuring to regularly check blood oxygen levels with an oximeter, which is available from leading pharmacies including the Medipost Pharmacy online shop,” Westerman notes.
“It is crucial that any medicine is only ever used according to the manufacturer’s or a healthcare professional’s advice, as inappropriate use can be harmful. When taken safely, however, paracetamol can bring immense relief for symptoms of pain and fever during recovery from colds, influenza and less severe cases of Covid-19,” she concluded.
Dr Michael de Villiers explains why people can become sick every flu season and why the influenza vaccine is generally recommended every year.
Colorectal cancer, one of the most prevalent yet preventable cancers, can develop in the colon or rectum, often starting as small polyps that can quietly become malignant if left unchecked. Dr Mpho Ramabulana, a colorectal surgeon and gastroenterologist at Netcare Akasia Hospital, underscores the life-saving power of vigilance and the importance of early detection.
Cardiologist Dr Robert Routier urges the public to check their personal risk factors regularly to help prevent or manage cardiovascular disease.
The physical strain pregnancy puts on an expectant mother’s body should not be underestimated. An obstetrician gynaecologist offers her insights for alleviating discomfort and promoting wellbeing with exercise and stretching throughout pregnancy.
Dr Patience Sigwadi, a leading paediatric nephrologist practising at Netcare Unitas Hospital in Centurion, has issued an urgent call for increased focus on skills development to address the escalating kidney disease crisis among children in South Africa.
Paediatric Nephrologist Professor Bhimma was recently awarded the Fellowship to acknowledge his extensive work in research, community-based outreach and teaching of paediatric nephrology, among others.
Netcare congratulates Professor Bhekifa Dube on his invitation to join the European Society for Vascular Surgery's clinical practice guidelines committee. His selection as the only specialist from the continent highlights the significance of this achievement on the global stage.
The lives of millions of South Africans with a litany of rare diseases can be vastly improved, and even saved, by addressing challenges in identifying, studying and treating their conditions. With Rare Disease Day on the 28th of February 2025, the Rare Diseases Access Initiative (RDAI) is driving an evolution of the country’s healthcare, through innovative strategies to better care for over 4.2million people living with an estimated 7000 rare diseases. “As our healthcare system faces significant changes in the years ahead, it is vital that we also advocate for people living with rare diseases in South Africa, especially those with limited healthcare access,” said Kelly du Plessis, CEO of Rare Diseases South Africa (RDSA), a member of RDAI. “As part of our ongoing research and awareness efforts, RDAI has conducted an initial analysis of the incidence and prevalence of rare diseases within the country.” This research will assist in improving access to healthcare, policy development, and patient advocacy, while giving critical insight into the challenges faced by patients. “According to research, some rare diseases affect fewer than 1 in a million people, while others, such as Down syndrome, cystic fibrosis, and haemophilia, have a more recognisable prevalence,” says Dr. Helen Malherbe, RDAI lead researcher on rare disease prevalence data. “Many conditions are undetected, underdiagnosed or misdiagnosed, with too many having no information available about them at all.” The RDAI was formed in 2019 to promote a more favourable environment for those impacted by rare diseases in South Africa. Participants include Ampath, the Board of Healthcare Funders (BHF), Discovery Health, Genetic Counsellors South Africa (SASHG), the Government Employees Medical Scheme (GEMS), Health Funders Association (HFA), Medihelp, Medscheme, North-West University (NWU), Rare Diseases South Africa (RDSA), the South African Medical Association (SAMA) and The South African Medical Technology Industry Association (SAMED). The Council for Medical Schemes (CMS) participates as an observer. In the same year, Rare Disease International signed a memorandum of understanding with the World Health Organisation leading to an international rare disease policy framework. In 2021, the United Nations General Assembly moved to adopt a resolution recognising 300 million people living with rare diseases worldwide. “A general lack of awareness and delayed diagnosis remain major hurdles for those affected by rare diseases. Policymakers and healthcare stakeholders need to prioritise access to treatment, diagnosis, and support for rare disease patients,” says Bada Pharasi, CEO of IPASA, “Through this initiative, working collaboratively with stakeholders at every level of the healthcare supply chain, we can bring real and meaningful change to those affected, including family members and care givers, through smart and efficient strategies.” The globally agreed definition of a rare disease is any medical condition with a specific pattern of clinical signs, symptoms, and findings that affects fewer than or equal to 1 in 2000 persons in a population. “Most are genetic, and some are inherited and passed down in families,” Malherbe says. “Some affect only the patient’s genetic recipe, while others may be acquired during life due to infection, trauma, or environmental effects. For many, the cause is still unknown. “These conditions mainly affect children, as they are largely incurable and many are life-threatening. Some require specialised and co-ordinated care, some have limited and expensive treatment options, while others have no information or effective treatments at all,” she adds. The RDAI is calling for a patient-centred care model built on equitable access, transparency and efficiency. Naturally, this model calls for the open participation of patients, the healthcare industry, health professionals, and the Government. “The most critical elements are robust diagnosis standards, improved access to treatment, data collection and management, co-ordination of care, measurement of outcomes and ongoing collaborative research,” du Plessis says. “We need to establish rare disease advisory committees, map gaps and opportunities, establish system requirements, create a roadmap and plan a phased implementation with clear timelines.” The RDAI states that these policy development steps would be a start in quantifying the disease burden and defining standards of care. This would be followed by building and strengthening the capacity to facilitate appropriate diagnosis, treatment, continuity and data monitoring. Thoneshan Naidoo, Chief Executive Officer of the Health Funders Association noted that, “We appreciate the unique opportunity provided by RDAI which enables stakeholders across the industry to work together and identify strategies that improve equitable access to the appropriate diagnosis, treatment and healthcare services for rare disease patients, in an affordable and sustainable manner, taking account of the other pressing needs across the healthcare system.” “True innovation in healthcare is only possible through partnerships and joint advocacy efforts that raise awareness and improve access to treatment. Our long-term goal is the development of a rare diseases policy framework and guidelines for coordinated care,” says Pharasi. “Our members are united in the commitment to unlocking improved patient outcomes and improving access to services and robust health needs assessment facilities.” he concludes. About RDAI The Rare Diseases Access Initiative (RDAI) is dedicated to advocating for improved healthcare access, policy development, and patient support for those affected by rare diseases in South Africa. The initiative brings together key healthcare stakeholders, including pharmaceutical associations, funders, genetic specialists, and patient advocacy groups, to drive impactful change. About RDSA Founded in 2013, Rare Diseases South Africa (RDSA) is a non-profit organisation advocating to ensure that people living with rare diseases and congenital disorders experience greater recognition, support, improved health service and better overall quality of life. Started out of personal need following the diagnosis of organisation founder, Kelly du Plessis' son, it became evident that there was a lack of awareness and support for rare diseases in general in South Africa. About IPASA The Innovative Pharmaceutical Association South Africa (IPASA) is a voluntary trade association representing 24 leading pharmaceutical companies committed to research, development, and innovation. Our mission is to drive healthcare advancement by advocating for policies that improve patient access to safe, high-quality, and affordable medicines.
Gastroenterologist Dr. Barbara Makumbi discusses common risk factors and offers tips for managing reflux and the longer-term condition known as gastroesophageal reflux disease (GORD).
From treating trauma injuries caused by wildlife, road accidents and sports, to heart attacks, stroke, or the sudden onset of other concerning medical symptoms – the emergency department at Netcare St Anne’s Hospital never sleeps.
